characteristics.text: SAMN45096054
characteristics.characteristic: External Id
characteristics.text: Kyushu University
characteristics.characteristic: INSDC center name
characteristics.text: 2025-12-31T00:58:56.767Z
characteristics.characteristic: INSDC first public
characteristics.text: 2025-12-31T00:58:56.767Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS23416111
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Human
characteristics.characteristic: NCBI submission model
characteristics.text: Human.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS23416111
characteristics.characteristic: SRA accession
characteristics.text: 20(MOLM13)_10(MV4-11)
characteristics.characteristic: age
characteristics.text: DSMZ(MOLM13)_ATCC(MV4-11)
characteristics.characteristic: biomaterial_provider
characteristics.text: 2021-09
characteristics.characteristic: collection_date
characteristics.text: This dataset contains RNA-seq data from MOLM13 and MV4-11 cell lines treated with Venetoclax alone or a combination of Venetoclax and Mycophenolic Acid (MPA). The aim of the study is to compare the gene expression profiles between these treatment groups to investigate the molecular mechanisms underlying the drug's effects. Total RNA was isolated and sequenced, and differential expression analysis was performed to identify genes and pathways influenced by the treatments.
characteristics.characteristic: description
characteristics.text: Japan: Fukuoka
characteristics.characteristic: geo_loc_name
characteristics.text: MOLM13_MV4-11_wt
characteristics.characteristic: isolate
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: male
characteristics.characteristic: sex
characteristics.text: Bone marrow
characteristics.characteristic: tissue
characteristics.text: MOLM13 and MV4-11 treated with Venetoclax alone or Venetoclax+Mycophenolic Acid (MPA)
characteristics.characteristic: title